Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis

International Archives of Allergy and Immunology

Volumn 149, Issue 2, 2009, Pages 111-118

  San Román, Beatriz ^a   Irache, Juan M ^a   Gómez, Sara ^a   Gamazo, Carlos ^a   Espuelas, Socorro ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Anaphylactic shock; CpG sequences; Immunotherapy; Poly(lactide co glycolide) microparticles

Indexed keywords

ALUMINUM HYDROXIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; NANOCARRIER; OLIGONUCLEOTIDE PHOSPHOROTHIOATE; OVALBUMIN; POLYGLACTIN;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE DISORDER; CHEMOPROPHYLAXIS; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DRUG DELIVERY SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; MICROENCAPSULATION; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; PROVOCATION TEST; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANAPHYLAXIS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DRUG CARRIERS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPH NODES; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; POLYGLACTIN 910; SPLEEN;

EID: 58149157489     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189193     Document Type: Article

References (25)

1. Bousquet J, Lockey R, Malling HJ: Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558-562.
2. Clemmensen O, Knudsen HE: Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Dermatitis 1980; 6:305-308.
3. Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M: Amb a 1-linked CpG oligo-deoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002; 109: 455-462.
4. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, Raz E: Conjugation of immunostimula-tory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000; 106:124-134.
5. Horner AA, Takabayashi K, Beck L, Sharma B, Zubeldia J, Baird S, Tuck S, Libet L, Spie-gelberg HL, Liu FT, Raz E: Optimized conjugation ratios lead to allergen immunostimu-latory oligodeoxynucleotide conjugates with retained immunogenicity and minimal ana-phylactogenicity. J Allergy Clin Immunol 2002; 110:413-420.
6. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM: Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001; 167: 3555-3558.
7. Maletto BA, Ropolo AS, Liscovsky MV, Ali-gnani DO, Glocker M, Pistoresi-Palencia MC: CpG oligodeoxinucleotides functions asan effective adjuvantinaged BALB/c mice. Clin Immunol 2005; 117:251-261.
8. Singh M, Ott G, Kazzaz J, Ugozzoli M, Briones M, Donnelly J, O'Hagan DT: Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA. Pharm Res 2001; 18:1476-1479.
9. Diwan M, Tafaghodi M, Samuel J: Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J Control Release 2002; 85:247-262.
10. Westwood A, Elvin SJ, Healey GD, Williamson ED, Eyles JE: Immunological responses after immunisation of mice with micropar-ticles containing antigen and single stranded R NA (polyuridylic acid). Vaccine 2006; 24: 1736-1743.
11. Elamanchili P, Diwan M, Cao M, Samuel J: Characterization of poly(D,L-lactic-co-gly-colic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 2004; 22: 2406-2412.
12. Martinez Gomez JM, Fischer S, Csaba N, Kundig TM, Merkle HP, Gander B, Johansen P: A protective allergy vaccine based on CpG- and protamine-containing PLGA mi-croparticles. Pharm Res 2007; 24: 1927-1935.
13. Zhang XQ, Dahle CE, Weiner GJ, Salem AK: A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles. J Pharm Sci 2007; 96:3283-3292.
14. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761-771.
15. Marazuela EG, Prado N, Moro E, Fernan-dez-Garcia H, Villalba M, Rodriguez R, Batanero E: Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization. Clin Exp Allergy 2008; 38:520-528.
16. Strong P, Clark H, Reid K: Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to dermatophagoides pteronyssinus and as-pergillus fumigatus in murine models of al-lergy. Clin Exp Allergy 2002; 32: 1794-1800.
17. del Barrio GG, Novo FJ, Irache JM: Loading of plasmid DNA into PLGA microparticles using troms (total recirculation one-machine system): evaluation of its integrity and controlled release properties. J Control Release 2003; 86:123-130.
18. Estevan M, Gamazo C, Gonzalez-Gaitano G, Irache JM: Optimization of the entrapment of bacterial cell envelope extracts into mi-croparticles for vaccine delivery. J Microen-capsul 2006; 23:169-181.
19. Roman BS, Espuelas S, Gomez S, Gamazo C, Sanz ML, Ferrer M, Irache JM: Intradermal immunization with ovalbumin-loaded poly-epsilon-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice. Clin Exp Allergy 2007; 37:287-295.
20. Steerenberg PA, van Dalen WJ, Withagen CE, Dormans JA, van Loveren H: Optimization of route of administration for coexpo-sure to ovalbumin and particle matter to induce adjuvant activity in respiratory allergy in the mouse. Inhal Toxicol 2003; 15: 1309-1325.
21. Li XM, Schofield BH, Huang CK, Kleiner GI, Sampson HA: A murine model of IgE-medi-ated cow's milk hypersensitivity. J Allergy Clin Immunol 1999; 103:206-214.
22. Watanabe N, Matsuda E, Masuda A, Nariai K, Shibasaki T: The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with trichinella spiralis. Int Immunopharmacol 2004; 4: 367-375.
23. Scholl I, Weissenbock A, Forster-Waldl E, Untersmayr E, Walter F, Willheim M, Boltz-Nitulescu G, Scheiner O, Gabor F, Jensen-Jarolim E: Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparti-cles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin Exp Allergy 2004; 34:315-321.
24. Jutel M, Akdis M, Budak F, Aebischer-Ca-saulta C, Wrzyszcz M, Blaser K, Akdis CA: IL-10 and TGF- β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-1214.
25. Kawano Y, Noma T, Yata J: Regulation of human IgG subclass production by cytokines: IFN-γ and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 1994; 153: 4948-4958.